Re: Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease [1]

Journal of the National Cancer Institute

Volumn 95, Issue 20, 2003, Pages 1552-

  Narod, Steven ^a   Lubinski, Jan ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE; ANTINEOPLASTIC AGENT; HORMONE;

AGE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; DIAGNOSTIC VALUE; GENE MUTATION; HEALTH HAZARD; HODGKIN DISEASE; HORMONE DETERMINATION; HUMAN; LETTER; MAMMOGRAPHY; MENOPAUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BREAST TUMOR; FEMALE; GENETICS; METABOLISM; NOTE; SECOND CANCER; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; GENES, BRCA1; HODGKIN DISEASE; HORMONES; HUMANS; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT;

EID: 0142180096     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djg078     Document Type: Letter

References (7)

1. van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van't Veer MB, Noordijk EM, et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 2003;95:971-80.
2. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, van't Veer L, Garber JE, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002; 346:1616-22.
3. Narod SA. Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer 2002;2:113-23.
4. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002;137(5 Part 1): 305-12.
5. Tabar L, Duffy SW, Vitak B, Chen HH, Prevost TC. The natural history of breast carcinoma: what have we learned from screening? Cancer 1999;86:449-62.
6. Brekelmans CT, Seynaeve C, Bartels CC, Tilanus-Linthorst MM, Meijers-Heijboer EJ, Crepin CM, et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 2001;19:924-30.
7. Warner E, Plewes DB, Shumak RS, Catzavelos GC, Di Prospero LS, Yaffe MJ, et al. Comparison of breast magnetic imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001;19:3524-31.